rLVS(delta) capB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli

By sjmartinez • May 27, 2025

Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Hum Vaccin Immunother. 2025 Dec;21(1):2507475. doi: 10.1080/21645515.2025.2507475. Epub 2025 May 26. PMID: 40417828.

Tags: bioterrorism, F1, Francisella tularensis, Infectious Diseases, LcrV, LVS ΔcapB, plague, Publications, single vector platform vaccine, Tier 1 select agent, vaccine, Yersinia pestis

Detection of Marburg Virus Antibodies 25 Years After Outbreak in Watsa, Democratic Republic of the Congo

Merritt S, Mukadi PK, Kompany JP, Halbrook M, Musene K, Martin SA, Beya M, Tambu M, Wong TAS, Muyembe-Tamfum JJ, Kaba DK, Lehrer AT, Kindrachuk[...]

Navigating Masculinities: An Exploration of Peer Coaching, Health Behaviors, and Mortality Risks Among Men in Tuberculosis and HIV Interventions in South Africa

Rutt K, DeVos L, Gala K, Njama T, Fosi M, Mhaleni Z, Daniels J, Medina-Marino A. Navigating Masculinities: An Exploration of Peer Coaching, Health Behaviors,[...]

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot GE, Brinson C, Buchbinder S, Molina JM, Gravett RM, Brock JB, Ramgopal MN, Rosengren AL, Ofotokun I, Valdez[...]